Reynders McVeigh Capital Management LLC Acquires 965 Shares of Clorox Co (NYSE:CLX)

Share on StockTwits

Reynders McVeigh Capital Management LLC boosted its holdings in shares of Clorox Co (NYSE:CLX) by 5.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 19,349 shares of the company’s stock after purchasing an additional 965 shares during the quarter. Reynders McVeigh Capital Management LLC’s holdings in Clorox were worth $2,963,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Dimensional Fund Advisors LP boosted its holdings in Clorox by 8.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 582,745 shares of the company’s stock valued at $89,822,000 after purchasing an additional 45,408 shares in the last quarter. Geode Capital Management LLC boosted its holdings in Clorox by 21.5% in the fourth quarter. Geode Capital Management LLC now owns 1,899,544 shares of the company’s stock valued at $292,347,000 after purchasing an additional 335,835 shares in the last quarter. Millennium Management LLC boosted its holdings in Clorox by 323.7% in the fourth quarter. Millennium Management LLC now owns 6,643 shares of the company’s stock valued at $1,024,000 after purchasing an additional 9,613 shares in the last quarter. Mercer Global Advisors Inc. ADV acquired a new position in Clorox in the first quarter valued at approximately $934,000. Finally, Oppenheimer & Co. Inc. boosted its holdings in Clorox by 8.3% in the first quarter. Oppenheimer & Co. Inc. now owns 16,439 shares of the company’s stock valued at $2,638,000 after purchasing an additional 1,254 shares in the last quarter. Hedge funds and other institutional investors own 75.88% of the company’s stock.

Shares of CLX stock traded down $3.22 during trading hours on Friday, hitting $155.93. The stock had a trading volume of 647,503 shares, compared to its average volume of 1,061,413. The firm has a market capitalization of $19.88 billion, a PE ratio of 24.67, a PEG ratio of 4.97 and a beta of 0.37. Clorox Co has a twelve month low of $141.53 and a twelve month high of $167.70. The stock’s 50 day moving average is $159.51 and its 200 day moving average is $155.89. The company has a debt-to-equity ratio of 4.09, a current ratio of 0.91 and a quick ratio of 0.55.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, August 1st. The company reported $1.88 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.84 by $0.04. The business had revenue of $1.63 billion during the quarter, compared to the consensus estimate of $1.69 billion. Clorox had a return on equity of 118.88% and a net margin of 13.20%. The company’s revenue was down 3.8% compared to the same quarter last year. During the same period in the prior year, the company earned $1.66 earnings per share. As a group, equities analysts predict that Clorox Co will post 6.4 earnings per share for the current year.

In related news, SVP Diego J. Barral sold 1,987 shares of the stock in a transaction on Friday, August 2nd. The stock was sold at an average price of $157.59, for a total transaction of $313,131.33. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Denise Garner sold 20,399 shares of the stock in a transaction on Friday, June 7th. The stock was sold at an average price of $157.61, for a total value of $3,215,086.39. Following the sale, the senior vice president now directly owns 4,896 shares of the company’s stock, valued at $771,658.56. The disclosure for this sale can be found here. Insiders sold 29,011 shares of company stock valued at $4,575,097 over the last three months. Corporate insiders own 1.40% of the company’s stock.

A number of equities analysts recently issued reports on the company. UBS Group upped their price target on Clorox from $110.00 to $128.00 and gave the company a “sell” rating in a report on Friday, August 2nd. Royal Bank of Canada upped their price target on Clorox to $161.00 and gave the company a “sector perform” rating in a report on Friday, August 2nd. Morgan Stanley upped their price target on Clorox from $141.00 to $144.00 and gave the company an “underweight” rating in a report on Friday, August 2nd. Zacks Investment Research raised Clorox from a “sell” rating to a “hold” rating and set a $175.00 price objective for the company in a report on Monday, July 29th. Finally, Deutsche Bank raised Clorox from a “sell” rating to a “hold” rating and set a $139.00 price objective for the company in a report on Thursday, May 2nd. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and two have given a buy rating to the stock. Clorox currently has an average rating of “Hold” and an average price target of $154.07.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Featured Story: Different Options Trading Strategies

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.